Feature Channels: Respiratory Diseases and Disorders

Filters close
Newswise: RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Released: 16-Jan-2024 5:05 AM EST
RUDN doctors: for personalized treatment of inflammation, individual sensitivity to hypoxia must be considered
Scientific Project Lomonosov

RUDN University doctors discovered that the body’s response to inflammation depends on individual sensitivity or resistance to oxygen deficiency.

Not for public release

This news release is embargoed until 15-Jan-2024 5:00 PM EST Released to reporters: 9-Jan-2024 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 15-Jan-2024 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 11-Jan-2024 6:05 PM EST
New ECMO Resources Include Online Course, Micro-credential
American Association of Critical-Care Nurses (AACN)

Nurses and other clinicians who care for patients with severe heart and lung failure receiving extracorporeal membrane oxygenation (ECMO) now have access to multiple resources from the American Association of Critical-Care Nurses, including specialized training and validation of their ECMO knowledge

   
9-Jan-2024 11:05 AM EST
High-dose radiotherapy with chemotherapy effective in treating people with non-small cell lung cancer
University of California, Los Angeles (UCLA), Health Sciences

A new study led by researchers from the UCLA Health Jonsson Comprehensive Cancer Center shows that using high doses of radiation while integrating an ablative radiotherapy technique called stereotactic ablative radiotherapy (SABR) concurrently with chemotherapy is safe and effective in treating people with locally advanced non-small cell lung cancer that is not suitable for surgery.

Newswise: COVID-19 affected Canadians with noncommunicable diseases more than those without, according to a new report
Released: 9-Jan-2024 5:05 PM EST
COVID-19 affected Canadians with noncommunicable diseases more than those without, according to a new report
Concordia University

Researchers at the Montreal Behavioural Medicine Centre (MBMC) say people with noncommunicable diseases (NCDs) such as heart disease, cancer, diabetes, or chronic lung ailments were disproportionately impacted by the COVID-19 pandemic.

Newswise:Video Embedded rise-of-the-tripledemic
VIDEO
Released: 5-Jan-2024 1:05 PM EST
Rise of the Tripledemic
Cedars-Sinai

As the new year kicks into full swing, so has a trio of respiratory viruses, creating a so-called tripledemic.

Released: 3-Jan-2024 2:05 PM EST
Inhaled statins show promise as effective asthma treatment
UC Davis Health

In an NIH-funded study, UC Davis pulmonology researchers are exploring whether delivering statins by inhalation can lead to better outcomes for people with asthma.

Newswise: The Lung Center At Mercy Introduces Interventional Pulmonology
Released: 2-Jan-2024 3:05 PM EST
The Lung Center At Mercy Introduces Interventional Pulmonology
Mercy Medical Center

The Lung Center at Mercy Medical Center is expanding to include Interventional Pulmonology (IP), essentially doubling the size of Mercy’s current Lung Center with greater access for pulmonary patients.

Newswise: Groundbreaking Study Reveals Indoor Metabolites as Key Indicators in Asthma and Allergic Rhinitis
Released: 21-Dec-2023 8:50 AM EST
Groundbreaking Study Reveals Indoor Metabolites as Key Indicators in Asthma and Allergic Rhinitis
Chinese Academy of Sciences

Millions of children worldwide suffer from asthma and allergic rhinitis (AR), two chronic respiratory conditions that significantly impact their quality of life.

15-Dec-2023 11:05 AM EST
Clinicians could be fooled by biased AI, despite explanations
Michigan Medicine - University of Michigan

The U.S. Food and Drug Administration has oversight of software powered by AI and machine learning used in healthcare and has issued guidance for developers, including a call to make the logic used by AI models to be transparent or explainable so that clinicians can review the underlying reasoning.

Not for public release

This news release is embargoed until 18-Dec-2023 5:00 PM EST Released to reporters: 12-Dec-2023 2:00 PM EST

A reporter's PressPass is required to access this story until the embargo expires on 18-Dec-2023 5:00 PM EST The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 15-Dec-2023 9:30 PM EST
Immune cells shape lung before birth and provide new avenues for treating respiratory diseases
Wellcome Trust Sanger Institute

Immune cells play an active and intimate role in directing the growth of human lung tissue during development, researchers find, revolutionising our understanding of early lung development and the role of immune cells outside of immunity.

Released: 13-Dec-2023 1:05 PM EST
‘Tis the season to get vaccinated: How to stay healthy through the holidays
Michigan Medicine - University of Michigan

With virus cases rising and the holidays nigh, three expert from University of Michigan Health give their top 12 tips for avoiding or reducing the impact of COVID-19, flu, RSV, pneumonia and whooping cough in adults and kids.

Newswise: Unique Cell-Based Approach for Pulmonary Arterial Hypertension Shown to Be Safe
Released: 13-Dec-2023 10:05 AM EST
Unique Cell-Based Approach for Pulmonary Arterial Hypertension Shown to Be Safe
Cedars-Sinai

Infusions of potentially therapeutic cells derived from the heart are safe for people with pulmonary arterial hypertension, a form of high blood pressure that occurs in the blood vessels of the lungs and typically affects middle-aged women, according to a study led by Cedars-Sinai investigators.

Newswise: Liquid Biopsy Predicts Immunotherapy Response and Toxicity in Patients with Advanced Lung Cancer
Released: 12-Dec-2023 11:00 AM EST
Liquid Biopsy Predicts Immunotherapy Response and Toxicity in Patients with Advanced Lung Cancer
Johns Hopkins Medicine

By monitoring changes in circulating tumor DNA (ctDNA) among 30 patients treated with immunotherapies for metastatic non-small cell lung cancers, researchers were able to determine molecular response — the clearance of tumor genetic material in the bloodstream.

Newswise: Researchers find promising candidate to treat irreversible lung and eye diseases in extremely premature infants
Released: 12-Dec-2023 6:05 AM EST
Researchers find promising candidate to treat irreversible lung and eye diseases in extremely premature infants
Elsevier

Advancements in the care of premature babies are leading to improved survival rates. However, the incidence of neonatal diseases with life-long consequences such as bronchopulmonary dysplasia (BPD) and retinopathy of prematurity (ROP) is increasing.

Released: 9-Dec-2023 10:05 AM EST
Major breakthrough for severe asthma treatment
King's College London

A landmark study has shown that severe asthma can be controlled using biologic therapies, without the addition of regular high-dose inhaled steroids which can have significant side effects.

Newswise: A dynamic picture of how we respond to high or low oxygen levels
Released: 9-Dec-2023 9:30 AM EST
A dynamic picture of how we respond to high or low oxygen levels
Gladstone Institutes

It only takes holding your breath for slightly too long to understand that too little oxygen is bad for you.

Newswise: The Medical Minute: Five home remedies can soothe your sore throat
Released: 7-Dec-2023 8:05 AM EST
The Medical Minute: Five home remedies can soothe your sore throat
Penn State Health

What can you do about that ache in your throat when you have a cold? A Penn State Heath family physician offers five remedies.

Newswise: A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
4-Dec-2023 11:05 AM EST
A Type of Allergy Medicine Might Help Treat Lung Cancer, Research Suggests
Mount Sinai Health System

Researchers at the Icahn School of Medicine at Mount Sinai have identified an allergy pathway that, when blocked, unleashes antitumor immunity in mouse models of non-small cell lung cancer (NSCLC). And in an early parallel study in humans, combining immunotherapy with dupilumab—an Interleukin-4 (IL-4) receptor-blocking antibody widely used for treating allergies and asthma—boosted patients' immune systems, with one out of the six experiencing significant tumor reduction. The findings were described in the December 6 issue of Nature.

Newswise: Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
Released: 6-Dec-2023 7:05 AM EST
Small but mighty: Microparticles from the placenta may offer major clues on the in utero development of neurobehavioral disorders
University of Missouri, Columbia

For 30 years, Cheryl Rosenfeld has studied how biological information gets transferred from mothers to babies during pregnancy.

Released: 5-Dec-2023 2:05 PM EST
Using AI to Speed — and Equalize — Medical Imaging
The Fannie and John Hertz Foundation

Hertz Fellow Sarah Hooper is developing solutions to reduce diagnostic imaging costs and address shortages and delays in radiology.

Released: 21-Nov-2023 3:45 PM EST
It's not over until it's over. Keep up with the latest COVID research in the Coronavirus channel.
Newswise

Stay informed! Keep up with the latest research on the COVID-19 virus in the Coronavirus channel on Newswise.

Newswise: Significant
Released: 18-Nov-2023 1:05 PM EST
Significant "post-COVID" resurgence in invasive meningococcal disease
Institut Pasteur

A team of scientists from the Institut Pasteur has used the database of the National Reference Center for Meningococci to trace the evolution of invasive meningococcal disease cases in France between 2015 and 2022, revealing an unprecedented resurgence in the disease after the easing of control measures imposed during the COVID-19 epidemic.

Newswise: First human clinical trial for pill-sized device that monitors breathing from the gut
Released: 18-Nov-2023 1:05 PM EST
First human clinical trial for pill-sized device that monitors breathing from the gut
Cell Press

Scientists have developed an ingestible device that can safely monitor vital signs like breathing and heart rate from inside humans. The tool, described November 17 in the journal Device, has the potential to provide accessible and convenient care for people at risk of opioid overdose.

Newswise: Survey finds many Americans are letting their guard down during respiratory illness season
Released: 13-Nov-2023 9:05 AM EST
Survey finds many Americans are letting their guard down during respiratory illness season
Ohio State University Wexner Medical Center

Despite the Centers for Disease Control and Prevention warning this year will be potentially dangerous for respiratory illnesses, a third of Americans are not concerned about the threat, according to a new national survey by The Ohio State University Wexner Medical Center.

Released: 13-Nov-2023 9:00 AM EST
Neurent Medical Announces New CPT Code® for Chronic Rhinitis Treatment Offering Significant Symptom Improvements
Neurent Medical

Neurent Medical, a company pioneering innovative non-surgical interventions to treat chronic inflammatory sinonasal diseases, today announced a significant milestone for the chronic rhinitis market.

Released: 10-Nov-2023 8:00 AM EST
Urgent Need for Increased Global Access to Effective Prevention and Treatment of Pneumonia
American Thoracic Society (ATS)

On World Pneumonia Day, Nov. 12, the Forum of International Respiratory Societies (FIRS), of which the American Thoracic Society is a founding member, is highlighting the urgent challenges in pneumonia prevention and treatment globally.

Newswise: UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
Released: 9-Nov-2023 4:05 PM EST
UTHealth Houston researchers awarded $2.6M NIH grant to study molecular pathways and potential strategies for treatment of myocardial ischemia and reperfusion injury
University of Texas Health Science Center at Houston

A four-year, $2.6 million grant to study circadian rhythm and novel therapies to protect the heart during a heart attack or cardiac surgery has been awarded to UTHealth Houston by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Newswise: Eliminating Mold After Natural Disasters is Vital for Those with Mold Allergy
3-Nov-2023 8:00 AM EDT
Eliminating Mold After Natural Disasters is Vital for Those with Mold Allergy
American College of Allergy, Asthma and Immunology (ACAAI)

Two new studies being presented at this year’s ACAAI Annual Scientific Meeting in Anaheim, Calif. show the harmful health effects of excess mold on those with asthma, while also discussing methods for getting rid of mold and other airborne allergens in the most efficient way possible.

Released: 8-Nov-2023 3:05 PM EST
Low-dose CT screening can catch lung cancer early - but most people overlook it
University of California, Los Angeles (UCLA), Health Sciences

November marks Lung Cancer Awareness Month and UCLA Health lung cancer experts are working to spread the word about the importance of low-dose computed tomography (LDCT) of the chest. The annual scan is recommended for people with a long-term history of smoking, as well as other criteria, including age.

Newswise: American College of Surgeons Supports National Lung Cancer Screening Day, Urges More Americans to Get Screened
Released: 8-Nov-2023 9:00 AM EST
American College of Surgeons Supports National Lung Cancer Screening Day, Urges More Americans to Get Screened
American College of Surgeons (ACS)

The American College of Surgeons (ACS) urges more Americans to take advantage of life-saving lung cancer screening.

Newswise: Systemic Sclerosis-associated Interstitial Lung Disease Focus of Latest Clinical Practice Guideline
Released: 8-Nov-2023 8:00 AM EST
Systemic Sclerosis-associated Interstitial Lung Disease Focus of Latest Clinical Practice Guideline
American Thoracic Society (ATS)

In patients with systemic sclerosis (SSc), a rare connective tissue disease, interstitial lung disease contributes to 35 percent of deaths. Published recently in the American Journal of Respiratory and Critical Care Medicine, the latest American Thoracic Society Clinical Practice Guideline makes a number of recommendations. One recommendation expands antifibrotic treatment to all patients with systemic sclerosis associated with ILD (SSc-ILD), not just those with progressive disease. Watch the explainer video.

Released: 7-Nov-2023 6:05 PM EST
Suspected bronchiectasis associated with higher risk of mortality in smokers
Brigham and Women’s Hospital

Bronchiectasis, a condition defined by widened lung airways, cough and sputum production, and frequent infections, often presents along with chronic obstructive pulmonary disease (COPD).

Released: 7-Nov-2023 11:05 AM EST
Risk of dying in hospital from respiratory causes is higher in the summer than in the winter
Barcelona Institute for Global Health, ISGlobal

A study analyzes the association between ambient temperature and hospital mortality from respiratory diseases in the provinces of Madrid and Barcelona

6-Nov-2023 1:05 PM EST
New strategy may halt tumors' aggressive response to glucose deprivation
University of California, Los Angeles (UCLA), Health Sciences

Researchers found that by restricting glucose in lung cancer cells, it caused the cells to lose their specialized features, making them more aggressive. This change was linked to alteration in certain molecules and how they modify DNA structure.

31-Oct-2023 11:05 AM EDT
Lung Cancer Screening Dramatically Increases Long-term Survival Rate
Mount Sinai Health System

Diagnosing early-stage lung cancer with low-dose computed tomography (CT) screening drastically improves its cure rate measured over a 20-year period, according to a large-scale international study by Mount Sinai researchers published in Radiology.

Released: 6-Nov-2023 10:05 AM EST
Nasal microorganism to the rescue? Study confirms protective role of bacterium in chronic rhinosinusitis
University of Fukui

Scientists investigate how microbes in the nasal mucosa may influence the pathophysiology of chronic sinusitis

Released: 2-Nov-2023 5:05 PM EDT
November is Lung Cancer Awareness Month; Indiana University experts available for interviews
Indiana University

November is Lung Cancer Awareness Month. Indiana University Melvin and Bren Simon Comprehensive Cancer Center’s scientists, physician-scientists, and staff are available to offer expertise in treatment innovations, the biology of lung cancers, research initiatives, and tips for smoking cessation.

Newswise: American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
30-Oct-2023 12:05 PM EDT
American Cancer Society Updates Lung Cancer Screening Guideline: Nearly Five Million U.S. Adults who Smoke and Formerly Smoked Now Recommended for Testing
American Cancer Society (ACS)

The American Cancer Society releasesan update of its lung cancer screening guideline to help reduce the number of people dying from the disease due to smoking history.

Newswise: Life-Changing Treatment for COPD Now Offered at Hackensack University Medical Center
Released: 30-Oct-2023 3:05 PM EDT
Life-Changing Treatment for COPD Now Offered at Hackensack University Medical Center
Hackensack Meridian Health

November is COPD Awareness Month, a recognition dedicated to raising awareness about Chronic Obstructive Pulmonary Disease (COPD), its impact on individuals and communities & the latest treatment options.

Newswise: UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome
Released: 26-Oct-2023 11:05 AM EDT
UTHealth Houston researchers awarded $3.4M NIH grant to study pharmaceutical therapies to treat acute respiratory distress syndrome
University of Texas Health Science Center at Houston

A four-year, $3.4 million grant to investigate molecular mechanisms and therapeutic treatments for acute respiratory distress syndrome (ARDS) has been awarded to UTHealth Houston researchers by the National Heart, Lung, and Blood Institute, part of the National Institutes of Health.

Released: 25-Oct-2023 9:30 AM EDT
Rutgers Awarded NIH Grant to Study How Previous Infections Affect Immune Response to Lung Disease
Rutgers University-New Brunswick

Researchers will examine how the body’s adaptations to viruses, fungi and parasites change its ability to combat unrelated respiratory infections.



close
2.1852